Article Sidebar
Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension
Abstract
The antihypertensive effects, as assessed by clinical and ambulatory blood pressure measurement, of nifedipine slowrelease (SR), atenolol and the two In combination were evaluated In 28 known hypertenslv88 In a placebo-controlled, double-blind, randomlsed cross-over trial. Clinical blood pressure was significantly lower on combination therapy (P< 0,025) than on either agent alone, although all therapeutic agents reduced blood pressure significantly when compared with placebo (P< 0,01). All ambulatory blood pressure measurements obtained on any therapeutic agent were significantly lower than those obtained on placebo (P < 0,01). The mean daytime (08h00 17h00) ambulatory blood pressure measurement as well as the percentage of this monitoring period dUring which patients were hypertensive were significantly lower (P < 0,01) on combination therapy than on nifedipine SR. A similar pattern was observed for 24-hour ambulatory blood pressure measurements. Headache was the most significant adverse effect. This was most common with nHedlplne SR, less common with combination therapy and least common with atenolol. Combination therapy with nifedipine SR and atenolol is therefore a viable therapeutic alternative in the treatment of patients with benign essential hypertension.
